The Role of Gastroesophageal Reflux in Provoking High Blood Pressure Episodes in Patients With Hypertension
- PMID: 28961574
- PMCID: PMC6110619
- DOI: 10.1097/MCG.0000000000000933
The Role of Gastroesophageal Reflux in Provoking High Blood Pressure Episodes in Patients With Hypertension
Abstract
Goals: We assessed the relationship between gastroesophageal reflux disease (GERD) and hypertension and whether antiacid therapy could be used to control blood pressure (BP) on hypertension in patients with GERD.
Background: Gastroesophageal reflux disease (GERD) may provoke cardiovascular disease. Many factors are involved in the development of essential hypertension, but whether GERD has a role needs further study.
Study: Patients with essential hypertension (n=86) were studied by 24-hour continuous BP monitoring and esophageal impedance and pH monitoring. Patients fulfilling the GERD criteria received 14-day therapy with omeprazole (20 mg twice a day), and the effect on BP was studied.
Results: Of the 86 essential hypertension patients, 38 (44.2%) had GERD. Among these 38 patients, 494 episodes of pathologic reflux (PR), and 684 episodes of high BP were recorded. PR was significantly more common at nighttime especially when supine. Of the 684 episodes of hypertension, 102 (14.9%) were synchronous with PR. GERD patients had significantly higher nocturnal BP than non-GERD patients. Antiacid therapy brought about significant reduction in all esophageal monitoring parameters as well as in BP parameters in GERD patients.
Conclusions: This study demonstrated that there is significant correlation between hypertension and GERD. Antiacid therapy can restore normal esophageal pH and help maintain normal BP.
Figures
Comment in
-
Gastroesophageal Reflux Treatment With Proton Pump Inhibitors in Patients With Hypertension.J Clin Gastroenterol. 2019 Feb;53(2):157-158. doi: 10.1097/MCG.0000000000001157. J Clin Gastroenterol. 2019. PMID: 30480567 No abstract available.
Similar articles
-
Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.Dis Esophagus. 2012 Nov-Dec;25(8):682-6. doi: 10.1111/j.1442-2050.2011.01310.x. Epub 2012 Jan 31. Dis Esophagus. 2012. PMID: 22292567
-
Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?Int J Cardiol. 2005 Sep 15;104(1):67-72. doi: 10.1016/j.ijcard.2004.10.018. Int J Cardiol. 2005. PMID: 16137512
-
Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?Am J Gastroenterol. 2008 Oct;103(10):2446-53. doi: 10.1111/j.1572-0241.2008.02033.x. Epub 2008 Aug 5. Am J Gastroenterol. 2008. PMID: 18684197 Clinical Trial.
-
Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.Dig Dis Sci. 2017 Aug;62(8):1881-1889. doi: 10.1007/s10620-017-4625-8. Epub 2017 May 26. Dig Dis Sci. 2017. PMID: 28550489 Review.
-
ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?Arq Gastroenterol. 2018 Nov;55Suppl 1(Suppl 1):85-91. doi: 10.1590/S0004-2803.201800000-48. Epub 2018 Oct 4. Arq Gastroenterol. 2018. PMID: 30304291 Review.
Cited by
-
Prevalence of reflux-related symptoms in South-Hungarian blood donor volunteers.PLoS One. 2022 Mar 15;17(3):e0265152. doi: 10.1371/journal.pone.0265152. eCollection 2022. PLoS One. 2022. PMID: 35290403 Free PMC article.
-
Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms.Diabetes Metab Syndr Obes. 2022 Jan 20;15:199-207. doi: 10.2147/DMSO.S339428. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35082506 Free PMC article.
References
-
- Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high BP: the JNC 7 report. JAMA. 2003;289:2560–2572. - PubMed
-
- Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223. - PubMed
-
- Storr M, Meining A, Allescher HD. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease. Dig Dis. 2000;18:93–102. - PubMed
-
- Vakil N, Van Zanten SV, Kahrilas P, et al. Global Consensus Group. The montreal definition and classification of gastro-esophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920. - PubMed
-
- Lux G, Van Els J, The GS, et al. Ambulatory oesophageal pressure, pH and ECG recording in patients with normal and pathological coronary angiography and intermittent chest pain. Neurogastroenterol Motil. 1995;7:23–30. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
